Why Choose Private Prescription for Weight Management?
Private vs NHS Route: Mounjaro vs Ozempic vs Wegovy Access
When comparing Mounjaro vs Ozempic vs Wegovy through the NHS, patients typically face a complex referral pathway requiring GP assessment, specialist weight management clinic appointments, and waiting periods exceeding 6 months in many UK regions. Private prescription eliminates these barriers entirely, offering direct access to clinically proven weight management medications through a streamlined digital assessment process. The key distinction lies in medication licensing: Wegovy (semaglutide) is specifically licensed for weight management, Mounjaro (tirzepatide) recently received UK approval for obesity treatment, whilst Ozempic remains licensed exclusively for type 2 diabetes management.
EverydayMeds provides both Wegovy and future access to Mounjaro through our GPhC-registered pharmacy (#9012878), ensuring patients receive genuine manufacturer medications with proper clinical oversight. Our private prescription service bypasses traditional healthcare bottlenecks whilst maintaining rigorous safety standards through qualified prescriber reviews and comprehensive patient monitoring systems.
Wegovy Pricing Structure and Bundle Value
Our transparent Wegovy pricing reflects the mandatory dose escalation protocol, starting with 0.25mg pens at £79.99 (with code FIRST40 for new customers). The progression continues through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), reaching the 2.4mg maintenance dose at £209.99 per pen. Returning customers benefit from code DOSE25 applied at checkout, maintaining competitive pricing throughout their treatment journey.
Bundle options provide convenience for extended treatment periods, including our Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99 covering the first 12 weeks of therapy. The Ultimate Stability Trio offers three months of 2.4mg maintenance dosing for £649.99, ensuring consistent supply without repeated ordering. All bundles include the same temperature-controlled delivery and clinical support as individual pen purchases.
Clinical Evidence: Mounjaro vs Ozempic vs Wegovy Efficacy
The STEP trial programme demonstrated Wegovy's clinical efficacy, with STEP 1 showing patients achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 confirmed sustained weight loss of approximately 15.2% maintained over 2 years of continuous treatment. The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events among patients taking semaglutide.
Mounjaro's SURMOUNT trials indicate the dual GIP/GLP-1 mechanism may offer additional benefits, though direct head-to-head comparisons between tirzepatide and semaglutide use different trial designs and patient populations. Both medications require combination with reduced-calorie diet and increased physical activity to achieve optimal outcomes as demonstrated in clinical settings.
How Wegovy Works for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones produced in the intestine. This mechanism targets appetite regulation centres in the brain, promoting feelings of satiety and fullness after smaller meal portions. The medication slows gastric emptying, extending the duration between meals and potentially reducing food cravings throughout the day. Clinical studies suggest this hormonal pathway modulation can support sustainable weight management when combined with appropriate lifestyle modifications. The once-weekly injection schedule helps maintain consistent therapeutic levels whilst minimising daily medication burden for long-term treatment adherence.
Streamlined Ordering Process for Private Prescription
Our digital assessment takes approximately 3 minutes to complete, covering medical history, current medications, weight management goals, and contraindication screening relevant to semaglutide therapy. Qualified prescribers review all applications within 3 working days (or 24 hours with express service), ensuring appropriate clinical oversight before dispensing this prescription-only medicine. Upon approval, orders are dispatched via next-day delivery using temperature-controlled packaging to maintain medication stability during transit. Each delivery includes comprehensive patient information leaflets, injection technique guidance, and access to ongoing clinical support throughout your treatment journey. Our pharmacy team remains available for questions regarding storage, administration, or potential side effects during your Wegovy therapy.
Storage Requirements and Practical Considerations
Wegovy pens require refrigerated storage between 2-8°C until first use, after which they may be kept at room temperature below 30°C for up to 6 weeks. This storage flexibility provides a significant advantage over Mounjaro's 21-day room temperature limit, making Wegovy more suitable for travel or varied storage situations. The FlexTouch delivery system provides accurate dosing with a simple click mechanism, whilst the needle safety system reduces injection anxiety for new users. Dose escalation follows a mandatory schedule over 16 weeks, gradually increasing tolerance whilst monitoring for potential gastrointestinal side effects. Each pen contains 4 doses, lasting exactly one month when administered weekly as prescribed.
Mounjaro vs Ozempic vs Wegovy: Mechanism and Licensing Differences
The fundamental difference between these medications lies in their receptor targeting and licensed indications within UK healthcare regulation. Wegovy's semaglutide targets GLP-1 receptors specifically, whilst Mounjaro's tirzepatide acts as a dual agonist affecting both GIP and GLP-1 pathways for potentially enhanced metabolic effects. Ozempic contains identical semaglutide to Wegovy but remains licensed exclusively for type 2 diabetes management, making its promotion for weight loss inappropriate within UK prescribing guidelines.
Both Wegovy and Mounjaro are available through EverydayMeds' private prescription service, allowing your prescriber to determine the most appropriate option based on individual medical history, treatment goals, and clinical presentation. Our pharmaceutical expertise ensures proper medication selection aligned with MHRA licensing requirements and current clinical best practice.
Complete Your Assessment Today
Start your private prescription journey with our 3-minute clinical assessment, designed by qualified healthcare professionals to ensure safe and appropriate Wegovy prescribing. New customers can apply discount code FIRST40 at checkout, whilst returning patients benefit from code DOSE25 for continued savings. Our next-day delivery service operates throughout the UK, providing discreet packaging and temperature-controlled transport for medication integrity. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and take the first step towards clinically supported weight management. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which treatment option aligns best with your individual healthcare needs and weight management objectives.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
